SCHEMBL10553489

SCHEMBL10553489

O=c1ccc(-c2ccc(-n3ccnc3)nc2)n[nH]1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 4/20 0.69
▸ PDE3A Q14432 4/20 0.69
▸ LMNA P02545 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ PIM1 P11309 1/20 0.44
▸ PDE2A O00408 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ CYP1A2 P05177 3/20 0.43
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ ADH5 P11766 3/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HRH3 Q9Y5N1 4/20 0.40
▸ ALOX5AP P20292 1/20 0.40
▸ KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7280366 0.82 PDE3B (1.00) PDE3BPDE3ALMNAKMT2APDE2A
SCHEMBL7276956 0.81 PDE3B (0.59) PDE3BPDE3ALMNAKMT2APIM1
SCHEMBL10551346 0.79 PDE3B (0.70) PDE3BPDE3ALMNAPIM1PDE2A
SCHEMBL12596036 0.75 PDE3B (0.64) PDE3BPDE3ALMNAKMT2APDE2A
SCHEMBL7287713 0.75 PDE3B (0.71) PDE3BPDE3AKMT2APDE2AMEN1
SCHEMBL12648802 0.73 PDE3B (0.60) PDE3BPDE3ALMNAKMT2APDE2A
SCHEMBL10648271 0.71 PDE3A (0.59) PDE3BPDE3ALMNAKMT2APDE2A
SCHEMBL7280421 0.70 PDE3B (0.61) PDE3BPDE3A
SCHEMBL10468427 0.70 PDE3B (0.69) PDE3BPDE3ALMNAPDE2ACYP1A2
SCHEMBL10551860 0.70 PDE3B (0.46) PDE3BPDE3ALMNAKMT2APIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4847251-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-07-11 — — US disclosed
EP-0255704-A2 Pyridazinone derivatives, process for their preparation and their use as medicines Roche Diagnostics GmbH (DE) 1988-02-10 — — EP disclosed
Send feedback